Navigation Links
Crusade Against Cancer: Collaborations On The Anvil

The IBM Corp., based in Armonk, N.Y., announced this Tuesday its decision to join forces with three research centers, as part of an overall effort to help accelerate cancer research, diagnosis and treatment//.

IBM will collaborate with the Memorial Sloan-Kettering Cancer Center, the Molecular Profiling Institute and the CHU Sainte-Justine Research Center under separate agreements.

IBM and Memorial Sloan-Kettering Cancer Center (MSKCC) will erect a state-of-the-art integrated information management system to improve the ability of clinicians and researchers to study long-term cancer-related illnesses, identify disease trends and determine success rates.

Funded by a $3 million grant of technology and services from IBM, MSKCC will include a comprehensive system to integrate its hospital data with text mining and related analytical capabilities into a unified information management environment to facilitate predictive analysis and research.

In addition, pathologists at MSKCC are working closely with researchers at IBM to create a searchable database for pathology reports.

"This is an excellent multi-sector model that can drive integration of molecular medicine into areas where it's truly needed, including cancer detection, treatment, and ultimately prevention," said Dr Anna Barker, deputy director of the National Cancer Institute (NCI). "The convergence of advanced technologies and post-genomics science will change cancer medicine in ways we cannot yet envision."

In a separate collaboration, cancer experts at three Manchester institutions have decided to work together at a new "world class" research center in the city. Researchers at Christie Hospital, the Paterson Institute and the University of Manchester will pool their efforts to find more effective treatments.

Their medical research will be coordinated by the newly-formed Manchester Cancer Research Center and it is hoped the center will come up with
'"/>




Page: 1 2

Related medicine news :

1. Organ Donation Crusader Passes Away
2. Crusade Against Malnutrition
3. Tuberculosis, A Challenge To The Political Will Of Governments, Says Veteran Crusader
4. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
5. Diabetics Need to Guard Against Nail Fungus
6. New Weapon Against Germs
7. Estrogen Found To Protect the Colon Against Cancer
8. Diet Found To Offer Protection Against Leukemia
9. Olive Oil Found To Offer A Protective Effect Against Breast Cancer
10. WHO Issues Caution Against Bird Flu Epidemic
11. New Supplement Found To Be Effective Against Sunburn
Post Your Comments:
Other Medicine News:Health News:GP targets on heart disease should be simpler and based more on treatment and prevention 2Health News:Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit 2Health News:Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit 3Health News:Exponent to Present at the Upcoming Sidoti & Company Investor Forum and William Blair Small-Cap Growth Stock Conference 2Health News:West Penn Allegheny Health System Selects Electronic Health Record From Allscripts 2Health News:West Penn Allegheny Health System Selects Electronic Health Record From Allscripts 3Health News:West Penn Allegheny Health System Selects Electronic Health Record From Allscripts 4Health News:AstraZeneca Joins Local Walking Movement 2Health News:AstraZeneca Joins Local Walking Movement 3Health News:AstraZeneca Joins Local Walking Movement 4Health News:Mother's milk a gift that keeps on giving 2Health News:Mother's milk a gift that keeps on giving 3Health News:Mother's milk a gift that keeps on giving 4
Breaking Medicine Technology:ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5MedicAlert Foundation International and CAP STS Collaborate to Standardize Emergency Medical Information 59051 1MedicAlert Foundation International and CAP STS Collaborate to Standardize Emergency Medical Information 59051 2MedicAlert Foundation International and CAP STS Collaborate to Standardize Emergency Medical Information 59051 3MedicAlert Foundation International and CAP STS Collaborate to Standardize Emergency Medical Information 59051 4Purolator USA Offers Advanced Tracking Capabilities for Medical Device Shipments 59046 1Purolator USA Offers Advanced Tracking Capabilities for Medical Device Shipments 59046 2Purolator USA Offers Advanced Tracking Capabilities for Medical Device Shipments 59046 3Free Pills from Government Boost Potassium Iodide Sales 59040 1Free Pills from Government Boost Potassium Iodide Sales 59040 2